SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-048981
Filing Date
2023-06-14
Accepted
2023-06-14 17:14:22
Documents
74
Period of Report
2023-04-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0423_enzobio.htm   iXBRL 10-Q 927315
2 CERTIFICATION f10q0423ex31-1_enzobio.htm EX-31.1 11017
3 CERTIFICATION f10q0423ex31-2_enzobio.htm EX-31.2 11092
4 CERTIFICATION f10q0423ex32-1_enzobio.htm EX-32.1 4118
5 CERTIFICATION f10q0423ex32-2_enzobio.htm EX-32.2 4157
  Complete submission text file 0001213900-23-048981.txt   5876325

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE enz-20230430.xsd EX-101.SCH 72607
7 XBRL CALCULATION FILE enz-20230430_cal.xml EX-101.CAL 44279
8 XBRL DEFINITION FILE enz-20230430_def.xml EX-101.DEF 260115
9 XBRL LABEL FILE enz-20230430_lab.xml EX-101.LAB 584828
10 XBRL PRESENTATION FILE enz-20230430_pre.xml EX-101.PRE 279557
68 EXTRACTED XBRL INSTANCE DOCUMENT f10q0423_enzobio_htm.xml XML 816340
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 231014996
SIC: 8071 Services-Medical Laboratories